Rigel Pharmaceuticals | RIGL - EPS Earnings Per Share


Rigel Pharmaceuticals reported $0.7 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agenus USD -0.3 0.84 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -0.93 1.15 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Celldex Therapeutics USD -1.18 0.04 Mar/2026
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 1.63 0.39 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Veracyte USD 0.52 0.01 Mar/2026